Cargando…

Cancer Stem Cell Markers—Clinical Relevance and Prognostic Value in High-Grade Serous Ovarian Cancer (HGSOC) Based on The Cancer Genome Atlas Analysis

Cancer stem cells (CSCs) may contribute to an increased risk of recurrence in ovarian cancer (OC). Further research is needed to identify associations between CSC markers and OC patients’ clinical outcomes with greater certainty. If they prove to be correct, in the future, the CSC markers can be use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iżycka, Natalia, Zaborowski, Mikołaj Piotr, Ciecierski, Łukasz, Jaz, Kamila, Szubert, Sebastian, Miedziarek, Cezary, Rezler, Marta, Piątek-Bajan, Kinga, Synakiewicz, Aneta, Jankowska, Anna, Figlerowicz, Marek, Sterzyńska, Karolina, Nowak-Markwitz, Ewa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454196/ https://www.ncbi.nlm.nih.gov/pubmed/37628927 http://dx.doi.org/10.3390/ijms241612746

Ejemplares similares

Choriocarcinoma complicated with intra-abdominal and intrapleural hemorrhage in pregnancy – case report
por: Jaz, Kamila, et al.
Publicado: (2023)

The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients
por: Izycka, Natalia, et al.
Publicado: (2023)

Serum Proteomic Profiles of Patients with High and Low Risk of Endometrial Cancer Recurrence
por: Pietkiewicz, Dagmara, et al.
Publicado: (2023)

Differential DNA methylation in high-grade serous ovarian cancer (HGSOC) is associated with tumor behavior
por: Reyes, Henry D., et al.
Publicado: (2019)

Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS)
por: Garziera, Marica, et al.
Publicado: (2018)

Validation analysis of the novel imaging-based prognostic radiomic signature in patients undergoing primary surgery for advanced high-grade serous ovarian cancer (HGSOC)
por: Fotopoulou, Christina, et al.
Publicado: (2021)

Retrospective Evaluation of Thromboembolism Risk in Ovarian Cancer Patients Treated with Bevacizumab
por: Kuk, Anna, et al.
Publicado: (2017)

Paraneoplastic neurological syndromes associated with ovarian tumors
por: Zaborowski, Mikolaj Piotr, et al.
Publicado: (2014)

CCNG1 (Cyclin G1) regulation by mutant‐P53 via induction of Notch3 expression promotes high‐grade serous ovarian cancer (HGSOC) tumorigenesis and progression
por: Xu, Ying, et al.
Publicado: (2018)

Human AGEs: an interactive spatio-temporal visualization and database of human archeogenomics
por: Ciecierski, Lukasz, et al.
Publicado: (2023)

Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC)
por: Garziera, Marica, et al.
Publicado: (2019)

Catamenial pneumothorax – are there benefits of cooperation between the surgeon and the gynaecologist?
por: Miedziarek, Cezary, et al.
Publicado: (2022)

Development of a 3D functional assay and identification of biomarkers, predictive for response of high-grade serous ovarian cancer (HGSOC) patients to poly-ADP ribose polymerase inhibitors (PARPis): targeted therapy
por: Sheta, Razan, et al.
Publicado: (2020)

The Expression and Role Analysis of Methylation-Regulated Differentially Expressed Gene UBE2C in Pan-Cancer, Especially for HGSOC
por: Li, Jiajia, et al.
Publicado: (2022)

3D dynamic cultures of HGSOC organoids to model innovative and standard therapies
por: Cavarzerani, Enrico, et al.
Publicado: (2023)

Estrogen Receptor-Beta2 (ERβ2)–Mutant p53–FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC)
por: Oturkar, Chetan C., et al.
Publicado: (2022)

Model Cell Lines and Tissues of Different HGSOC Subtypes Differ in Local Estrogen Biosynthesis
por: Pavlič, Renata, et al.
Publicado: (2022)

Progesterone prevents HGSOC by promoting precancerous cell pyroptosis via inducing fibroblast paracrine
por: Wu, Nayiyuan, et al.
Publicado: (2023)

Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomes
por: Cunnea, Paula, et al.
Publicado: (2023)

Immunotherapy in Ovarian Cancer
por: Siminiak, Natalia, et al.
Publicado: (2022)

RAD51D Secondary Mutation-Mediated Resistance to PARP-Inhibitor-Based Therapy in HGSOC
por: Xu, Jing, et al.
Publicado: (2023)

The Influence of the Sous Vide Cooking Time on Selected Characteristics of Pork Lion
por: Rezler, Ryszard, et al.
Publicado: (2023)

Human Chorionic Gonadotropin Beta Subunit Genes CGB1 and CGB2 are Transcriptionally Active in Ovarian Cancer
por: Kubiczak, Marta, et al.
Publicado: (2013)

Misinformation, Fears and Adherence to Preventive Measures during the Early Phase of COVID-19 Pandemic: A Cross-Sectional Study in Poland
por: Nowak, Bartosz M., et al.
Publicado: (2021)

MiR-509-3 augments the synthetic lethality of PARPi by regulating HR repair in PDX model of HGSOC
por: Sun, Chenggong, et al.
Publicado: (2020)

A chemotherapy response prediction model derived from tumor-promoting B and Tregs and proinflammatory macrophages in HGSOC
por: Xi, Yue, et al.
Publicado: (2023)

Classification of masked image data
por: Lis, Kamila, et al.
Publicado: (2021)

MRE11:p.K464R mutation mediates olaparib resistance by enhancing DNA damage repair in HGSOC
por: Zhuang, Xucui, et al.
Publicado: (2023)

Importance of Potential New Biomarkers in Patient with Serouse Ovarian Cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2021)

A Cluster Analysis of Risk Factors for Cancer across EU Countries: Health Policy Recommendations for Prevention
por: Majcherek, Dawid, et al.
Publicado: (2021)

The Influence of Angiotensin Peptides on Survival and Motility of Human High-Grade Serous Ovarian Cancer Cells in Serum Starvation Conditions
por: Domińska, Kamila, et al.
Publicado: (2021)

Regulation of miRNA Processing and miRNA Mediated Gene Repression in Cancer
por: Bajan, Sarah, et al.
Publicado: (2014)

Colorectal Cancer in the Young: Research in Early Age Colorectal Cancer Trends (REACCT) Collaborative
por: Zaborowski, Alexandra M.
Publicado: (2023)

Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib
por: Eismann, Julia, et al.
Publicado: (2019)

Granzyme B in peripheral blood mononuclear cells as a measure of cell-mediated immune response in paraneoplastic neurological syndromes and malignancy
por: Zaborowski, Mikołaj Piotr, et al.
Publicado: (2020)

Pathway-level mutation analysis in primary high-grade serous ovarian cancer and matched brain metastases
por: Duchnowska, Renata, et al.
Publicado: (2022)

Mass spectrometry imaging in gynecological cancers: the best is yet to come
por: Pietkiewicz, Dagmara, et al.
Publicado: (2022)

Regulation of human chorionic gonadotropin beta subunit expression in ovarian cancer
por: Śliwa, Aleksandra, et al.
Publicado: (2019)

Sympathetic nervous signaling dictates prostate cancer progression
por: Sigorski, D., et al.
Publicado: (2022)

Notch signaling in serous ovarian cancer
por: Groeneweg, Jolijn W, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mfbf3b5hdofggss88c1df4666f